Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Nutra Pharma - aVenture Company Research

Nutra Pharma

Nutra Pharma

Nutra Pharma Corp. is a biopharmaceutical company specializing in the development and commercialization of treatments for neurological, autoimmune, and infectious diseases.

Coral Springs, FL, US🇺🇸

Founded

Nutra Pharma Corp., founded as a biopharmaceutical company, focuses on the acquisition, licensing, and commercialization of pharmaceutical products and technologies aimed at treating neurological disorders, cancer, autoimmune, and infectious diseases. Their core mission is to bring innovative healthcare solutions to the world. Through its subsidiary, ReceptoPharm, Inc., Nutra Pharma develops products such as RPI-78M for neurological diseases including multiple sclerosis and amyotrophic lateral sclerosis, and RPI-MN for viral infections.

Notable affiliated individuals include the company's leadership team and scientific advisors who contribute to its research and development efforts. Nutra Pharma has garnered attention from investors interested in biopharmaceutical innovations. Key achievements include the development of promising drug candidates and the expansion of their product pipeline. The overall impact of Nutra Pharma lies in its potential to offer novel treatments for debilitating conditions, thereby improving patient outcomes and advancing medical science.

Nutra Pharma - Similar Companies

NeuroTherapeutics Pharma

Neurana Pharmaceuticals

neuranapharma.com

NeuroPro Therapeutics

Nutra Pharma - Quick Facts

Who are Nutra Pharma's competitors?

Companies similar to Nutra Pharma include NeuroTherapeutics Pharma, Neurana Pharmaceuticals, NeuroPro Therapeutics and NutraLife Biosciences.

When was Nutra Pharma founded?

Nutra Pharma was founded in 2000.

Where is Nutra Pharma's headquarters located?

Nutra Pharma's headquarters is located in Coral Springs, FL, US.

How many employees does Nutra Pharma have?

Nutra Pharma has 4 employees as of Feb 5, 2024.

Nutra Pharma - Classification

Ownership: Public
Technology: Biotech
Geographic Exposure: Global

Revenue

Licensing
Recurring
Software

Customer

Enterprise

Main Product

Pharmaceuticals

Tags: Biotech
Healthcare
Healthtech

Ticker: NPHC
SEC CIK: 0001119643

NAICS: 540000Professional, Scientific, and Technical Services
541714Research and Development in Biotechnology (except Nanobiotechnology)
541000Professional, Scientific, and Technical Services
541700Scientific Research and Development Services
541710Research and Development in the Physical, Engineering, and Life Sciences
SIC: 2833Medicinal Chemicals And Botanical Products
2800Chemicals And Allied Products
2830Drugs
ISIC: 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products

Show 16 more industry codes

NAICS: 320000Manufacturing
325400Pharmaceutical and Medicine Manufacturing
325411Medicinal and Botanical Manufacturing
620000Health Care and Social Assistance
325000Chemical Manufacturing
623000Nursing and Residential Care Facilities
325410Pharmaceutical and Medicine Manufacturing
325412Pharmaceutical Preparation Manufacturing

NutraLife Biosciences

Navitor Pharmaceuticals

Pharmatrophix

pharmatrophix.com

Neurovia

Nura Bio

nurabio.com

Bioadaptives

bioadaptives.com

Integrated BioPharma

ibiopharma.com

Harmony Biosciences

Pharmos

pharmoscorp.com

Zocere

zocere.com

NeuroFine

ReNeuroGen

rngen.com

SIC

4000Railroad Transportation
8000Health Services
8700Engineering, Accounting, Research, Management, And Related Services
8040Offices And Clinics Of Other Health Practitioners
8730Research, Development, And Testing Services
2834Pharmaceutical Preparations
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
8731Commercial Physical and Biological Research